Find the right fit for you - faster
Get tailored insights about working at Clovis Oncology in one quick step.
Clovis Oncology Snapshot
Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy.
Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy.
